A. Perelas

Navigating the Complexity of PH-ILD: From Molecular Mechanisms to Integrated Clinical Evaluation

Pulmonary Hypertension (PH) in patients with Interstitial Lung Disease (ILD) is a critical, yet underrecognized, complication that affects patients’ quality of life and increases mortality. Emerging evidence further suggests that PH-ILD is not merely a consequence of hypoxia and parenchymal fibrosis, as the severity of...